Last reviewed · How we verify
TIVA
At a glance
| Generic name | TIVA |
|---|---|
| Also known as | Fentanyl, propofol, Placebo, Controll, Total Intra Venous Anesthesia |
| Sponsor | Ain Shams University |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- DSA vs. BIS for Anesthesia and Analgesia Management
- Total Intravenous and Balanced Anesthesia in Diabetic Patients Undergoing Video-Assisted Thoracoscopy (PHASE4)
- Hemodynamic Effects of Remimazolam vs Propofol During Robot-assisted Gynecologic Surgery (NA)
- Comparison of Target-Controlled and Manual Total Intravenous Anesthesia in Supratentorial Surgery (NA)
- The Impact of Automatic Lung Recruitment Postoperative Pulmonary Complications (NA)
- Post-Hoc Cost-Utility Analysis of Ultrasound-Guided Erector Spinae Plane (ESP) Block Versus Total Intravenous Anesthesia (TIVA) in Posterior Scoliosis Correction Surgery: Evidence From the Egyptian EQ-5D-5L Value Set
- Comparison of Anesthetic Techniques for Early Recovery After Ankle Arthroscopy (NA)
- Remimazolam TIVA-Flumazenil Antagonism in Short-duration ENT Surgeries
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- TIVA CI brief — competitive landscape report
- TIVA updates RSS · CI watch RSS
- Ain Shams University portfolio CI